Devises / MYGN
MYGN: Myriad Genetics Inc
6.37
USD
0.15
(2.41%)
Le taux de change de MYGN a changé de 2.41% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 6.21 et à un maximum de 6.56.
Suivez la dynamique Myriad Genetics Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
MYGN Nouvelles
- Myriad Genetics stock rating reiterated at Neutral by UBS with $6 target
- Myriad Genetics soars 65% following InvestingPro’s May fair value alert
- Myriad: HCT In Oncology Continues To Deliver Increased Volume And Revenue
- U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.19%
- Shopify, Astera Labs, Myriad Genetics, Grocery Outlet And Other Big Stocks Moving Higher On Wednesday - Astera Labs (NASDAQ:ALAB), Arista Networks (NYSE:ANET)
- Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Astera Labs (NASDAQ:ALAB), Digital Turbine (NASDAQ:APPS)
- Myriad Genetics, Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:MYGN)
- Myriad Genetics, Inc. (MYGN) Q2 2025 Earnings Call Transcript
- Myriad Genetics (MYGN) Q2 Revenue Up 6%
- Compared to Estimates, Myriad (MYGN) Q2 Earnings: A Look at Key Metrics
- Myriad Genetics (MYGN) Q2 Earnings and Revenues Surpass Estimates
- Myriad Genetics Q2 2025 slides: revenue growth accelerates, guidance raised
- Myriad Genetics earnings beat by $0.06, revenue topped estimates
- Myriad Genetics secures $200 million credit facility from OrbiMed
- Piper Sandler sees opportunity in dislocated Life Science stocks
- Myriad Genetics at Goldman Sachs Conference: Strategic Growth Amid Challenges
- Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen
- Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types
- Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
- Scotiabank cuts Myriad Genetics stock rating, slashes price target
- This UnitedHealth Group Analyst Turns Bearish; Here Are Top 3 Downgrades For Wednesday - Pennant Park Investment (NYSE:PNNT), Myriad Genetics (NASDAQ:MYGN)
- CI&T, Novavax, Paramount Group And Other Big Stocks Moving Higher On Monday - Avino Silver & Gold Mines (AMEX:ASM), BGC Group (NASDAQ:BGC)
- Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
- Crude Oil Falls 1%; Uber Sales Miss Estimates - CuriosityStream (NASDAQ:CURI), Asset Entities (NASDAQ:ASST)
Range quotidien
6.21
6.56
Range Annuel
3.76
29.30
- Clôture Précédente
- 6.22
- Ouverture
- 6.25
- Bid
- 6.37
- Ask
- 6.67
- Plus Bas
- 6.21
- Plus Haut
- 6.56
- Volume
- 2.170 K
- Changement quotidien
- 2.41%
- Changement Mensuel
- 69.41%
- Changement à 6 Mois
- -41.02%
- Changement Annuel
- -77.48%
31 août, dimanche